Literature DB >> 11588043

Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells.

A W Langerak1, I L Wolvers-Tettero, E J van Gastel-Mol, M E Oud, J J van Dongen.   

Abstract

T-cell receptor (TCR) gene rearrangements are mediated via V(D)J recombination, which is strictly regulated during lymphoid differentiation, most probably through the action of specific transcription factors. Investigated was whether cotransfection of RAG1 and RAG2 genes in combination with lymphoid transcription factors can induce TCR gene rearrangements in nonlymphoid human cells. Transfection experiments showed that basic helix-loop-helix transcription factors E2A and HEB induce rearrangements in the TCRD locus (Ddelta2-Ddelta3 and Vdelta2-Ddelta3) and TCRG locus (psi Vgamma7-Jgamma2.3 and Vgamma8-Jgamma2.3). Analysis of these rearrangements and their circular excision products revealed some peculiar characteristics. The Vdelta2-Ddelta3 rearrangements were formed by direct coupling without intermediate Ddelta2 gene segment usage, and most Ddelta2-Ddelta3 recombinations occurred via direct coupling of the respective upstream and downstream recombination signal sequences (RSSs) with deletion of the Ddelta2 and Ddelta3 coding sequences. Subsequently, the E2A/HEB-induced TCR gene recombination patterns were compared with those in early thymocytes and acute lymphoblastic leukemias of T- and B-lineage origin, and it was found that the TCR rearrangements in the transfectants were early (immature) and not necessarily T-lineage specific. Apparently, some parts of the TCRD (Vdelta2-Ddelta region) and TCRG genes are accessible for recombination not only in T cells, but also in early B-cells and even in nonlymphoid cells if the appropriate transcription factors are present. The transfection system described here appeared to be useful for studying the accessibility of immunoglobulin and TCR genes for V(D)J recombination, but might also be applied to study the induction of RSS-mediated chromosome aberrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588043     DOI: 10.1182/blood.v98.8.2456

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

2.  Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis.

Authors:  Jana Volejnikova; Ester Mejstrikova; Tatana Valova; Leona Reznickova; Ladislava Hodonska; Vladimir Mihal; Jaroslav Sterba; Yahia Jabali; Daniela Prochazkova; Bohumir Blazek; Jiri Hak; Zdenka Cerna; Ondrej Hrusak; Jan Stary; Jan Trka; Eva Fronkova
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

3.  Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL.

Authors:  M Kotrova; V H J van der Velden; J J M van Dongen; R Formankova; P Sedlacek; M Brüggemann; J Zuna; J Stary; J Trka; E Fronkova
Journal:  Bone Marrow Transplant       Date:  2017-02-27       Impact factor: 5.483

Review 4.  Helix-Loop-Helix Proteins in Adaptive Immune Development.

Authors:  Megan Aubrey; Zachary J Warburg; Cornelis Murre
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 5.  E proteins in lymphocyte development and lymphoid diseases.

Authors:  Ian Belle; Yuan Zhuang
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

6.  New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling.

Authors:  Willem A Dik; Karin Pike-Overzet; Floor Weerkamp; Dick de Ridder; Edwin F E de Haas; Miranda R M Baert; Peter van der Spek; Esther E L Koster; Marcel J T Reinders; Jacques J M van Dongen; Anton W Langerak; Frank J T Staal
Journal:  J Exp Med       Date:  2005-05-31       Impact factor: 14.307

7.  E47 is required for V(D)J recombinase activity in common lymphoid progenitors.

Authors:  Lisa Borghesi; Jennifer Aites; Shakira Nelson; Preslav Lefterov; Pamela James; Rachel Gerstein
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

8.  RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement.

Authors:  Agata Cieslak; Sandrine Le Noir; Amélie Trinquand; Ludovic Lhermitte; Don-Marc Franchini; Patrick Villarese; Stéphanie Gon; Jonathan Bond; Mathieu Simonin; Laurent Vanhille; Laurent Vanhile; Christian Reimann; Els Verhoeyen; Jerome Larghero; Emmanuelle Six; Salvatore Spicuglia; Isabelle André-Schmutz; Anton Langerak; Bertrand Nadel; Elizabeth Macintyre; Dominique Payet-Bornet; Vahid Asnafi
Journal:  J Exp Med       Date:  2014-08-18       Impact factor: 14.307

9.  Aberrant production of IL-13 by T cells promotes exocrinopathy in Id3 knockout mice.

Authors:  Ian Belle; Josh Mahlios; Andrew McKenzie; Yuan Zhuang
Journal:  Cytokine       Date:  2014-07-07       Impact factor: 3.861

10.  The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study.

Authors:  Carl E Allen; Chi-ho Mak; Lai-Chu Wu
Journal:  BMC Immunol       Date:  2002-08-22       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.